Sequenom Provides Further Details on T21 Test Timeline | GenomeWeb

By Edward Winnick

NEW YORK (GenomeWeb News) – A Sequenom official yesterday provided an update on the firm's timeline for commercialization of its highly anticipated trisomy 21 non-invasive, pre-natal test.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genetic history of HIV in the US, and more.

There are a few projects aimed at addressing the lack of diversity in genomic research, Technology Review reports.

A national assessment shows that US students lag in the sciences, but suggests that achievement gaps are narrowing.

Harvard's George Church discusses HGP-write with the Journal of the American Medical Association.